大陆心血管论文被引TOP 100出炉:陈绍良以703次称冠

2015-09-09 心血管杂志 中国心血管杂志

2004-2015年,在中国大陆被引频次100名之内的文章中,来自北京的论文数量最多,共34篇;上海发表的论文平均被引次数最高,平均每篇被引105.6次。陈绍良一人就有3篇高引用次数的论文,平均引用次数为273次,他一项有关干细胞的研究被引频率高达703次。TOP 100文章中,一半为基础研究,43篇为临床研究,6篇为Meta分析,1篇综述。43项临床研究中,13项为随机临床研究,其余30项为观察

2004-2015年,在中国大陆被引频次100名之内的文章中,来自北京的论文数量最多,共34篇;上海发表的论文平均被引次数最高,平均每篇被引105.6次。陈绍良一人就有3篇高引用次数的论文,平均引用次数为273次,他一项有关干细胞的研究被引频率高达703次。TOP 100文章中,一半为基础研究,43篇为临床研究,6篇为Meta分析,1篇综述。43项临床研究中,13项为随机临床研究,其余30项为观察性研究。

我国的心血管医生数量虽然全球最多,但高水平论文数量并不如意。近期,广东省人民医院谭宁教授等公布了2004-2015年中国大陆引用次数最多的100篇心血管领域论文。

这100篇论文平均引用次数为91.6次,引用次数最多的达703次,引用次数最少的为50次,只有4篇论文引用次数超过200次。

引用次数最多的文章来自于南京医科大学附属南京第一医院,于2004年发表在《American Journal of Cardiology(美国心脏病学杂志)》,是一项在急性心肌梗死患者中评估自体骨髓造血干细胞冠脉内移植对左心室射血分数的影响的研究(文末表1),被引频率高达703次。

这篇文章的第一作者是陈绍良,他一人就有3篇高引用次数的论文,平均引用次数为273次。

这100篇论文发表在不同的29本杂志上,在《Circulation》杂志上发表的论文数量最多,有14篇;其后依次是《Cardiovascular Research》(10篇)、《JACC》(10篇)、《Atherosclerosis》(7篇)、《Circulation Research》(7篇)、《European Heart Journal》 (7篇)和《International Journal of Cardiology》(6篇)。世界顶尖的三大综合医学期刊即《New England Journal of Medicine(新英格兰医学杂志)》、《Lancet(柳叶刀)》和《JAMA(美国医学会杂志)》中,中国心血管医生仅在《JAMA》上发表了一篇引用次数进前100名的论文。

在这些论文中,67%发表于2006-2009年,这4年期间平均每年的被引用次数为216次(图1)。然而,近3年没有论文引用次数进前100名。



1 2004-2012年发表的文章数量和引用总次数

这些论文来自于全国16个省/市,北京发表的论文数量最多,共发表了34篇;其后依次是上海(15篇)、浙江(7篇)、山西(7篇)、湖北(6篇)和广东(5篇)。上海发表的论文引用总次数最高,平均每篇论文被引用105.6次(图2)。


2 100篇引用次数最多的论文中不同省份产出的论文数量(A)和引用总次数(B)

在这100篇论文中,一半为基础研究,43篇为临床研究,6篇为Meta分析,1篇综述。43项临床研究中,13项为随机临床研究,其余30项为观察性研究。这些研究主要涉及冠脉疾病(21项)、流行病学(4项)、心律失常(4项)、心脏外科(3项)、心衰(2项)、高血压(2项)、先心病(1项),其他6项。临床研究的平均引用次数最高,每篇论文平均被引用102.6次(图3)。



3 不同类型论文数量及其引用总次数


在引用次数超过100次的论文中,临床研究中引用次数最多的是急性心肌梗死研究(3项,27.3%),基础研究中为干细胞研究(4项,33.3%)。


文献出处:Yuan-hui Liu, Sheng-qi Wang, Jin-hua Xue, et al. The 100 most-cited articles on cardiovascular diseases from Mainland China. BMC Cardiovasc Disord, 2015, 15: 94.


2004-2015年中国大陆引用次数最多的100篇心血管论文

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=36686, encodeId=8d1836686a9, content=院长大人威武!, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150901/IMG55E5AEBA878A11723.jpg, createdBy=1a101647541, createdName=Mokgreen , createdTime=Thu Sep 10 21:39:00 CST 2015, time=2015-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36687, encodeId=d2993668e28, content=院长大人威武!, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150901/IMG55E5AEBA878A11723.jpg, createdBy=1a101647541, createdName=Mokgreen , createdTime=Thu Sep 10 21:39:00 CST 2015, time=2015-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36688, encodeId=24ba3668847, content=院长大人威武!, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150901/IMG55E5AEBA878A11723.jpg, createdBy=1a101647541, createdName=Mokgreen , createdTime=Thu Sep 10 21:39:00 CST 2015, time=2015-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36614, encodeId=558736614f1, content=赞\(≧▽≦)/, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=121e1622385, createdName=chenhui888, createdTime=Thu Sep 10 09:23:00 CST 2015, time=2015-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36611, encodeId=d5193661192, content=陈绍良果然厉害,是PCI一把好手!临床与科研齐头并进的人物, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed Sep 09 22:52:00 CST 2015, time=2015-09-09, status=1, ipAttribution=)]
    2015-09-10 Mokgreen

    院长大人威武!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=36686, encodeId=8d1836686a9, content=院长大人威武!, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150901/IMG55E5AEBA878A11723.jpg, createdBy=1a101647541, createdName=Mokgreen , createdTime=Thu Sep 10 21:39:00 CST 2015, time=2015-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36687, encodeId=d2993668e28, content=院长大人威武!, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150901/IMG55E5AEBA878A11723.jpg, createdBy=1a101647541, createdName=Mokgreen , createdTime=Thu Sep 10 21:39:00 CST 2015, time=2015-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36688, encodeId=24ba3668847, content=院长大人威武!, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150901/IMG55E5AEBA878A11723.jpg, createdBy=1a101647541, createdName=Mokgreen , createdTime=Thu Sep 10 21:39:00 CST 2015, time=2015-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36614, encodeId=558736614f1, content=赞\(≧▽≦)/, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=121e1622385, createdName=chenhui888, createdTime=Thu Sep 10 09:23:00 CST 2015, time=2015-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36611, encodeId=d5193661192, content=陈绍良果然厉害,是PCI一把好手!临床与科研齐头并进的人物, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed Sep 09 22:52:00 CST 2015, time=2015-09-09, status=1, ipAttribution=)]
    2015-09-10 Mokgreen

    院长大人威武!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=36686, encodeId=8d1836686a9, content=院长大人威武!, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150901/IMG55E5AEBA878A11723.jpg, createdBy=1a101647541, createdName=Mokgreen , createdTime=Thu Sep 10 21:39:00 CST 2015, time=2015-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36687, encodeId=d2993668e28, content=院长大人威武!, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150901/IMG55E5AEBA878A11723.jpg, createdBy=1a101647541, createdName=Mokgreen , createdTime=Thu Sep 10 21:39:00 CST 2015, time=2015-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36688, encodeId=24ba3668847, content=院长大人威武!, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150901/IMG55E5AEBA878A11723.jpg, createdBy=1a101647541, createdName=Mokgreen , createdTime=Thu Sep 10 21:39:00 CST 2015, time=2015-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36614, encodeId=558736614f1, content=赞\(≧▽≦)/, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=121e1622385, createdName=chenhui888, createdTime=Thu Sep 10 09:23:00 CST 2015, time=2015-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36611, encodeId=d5193661192, content=陈绍良果然厉害,是PCI一把好手!临床与科研齐头并进的人物, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed Sep 09 22:52:00 CST 2015, time=2015-09-09, status=1, ipAttribution=)]
    2015-09-10 Mokgreen

    院长大人威武!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=36686, encodeId=8d1836686a9, content=院长大人威武!, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150901/IMG55E5AEBA878A11723.jpg, createdBy=1a101647541, createdName=Mokgreen , createdTime=Thu Sep 10 21:39:00 CST 2015, time=2015-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36687, encodeId=d2993668e28, content=院长大人威武!, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150901/IMG55E5AEBA878A11723.jpg, createdBy=1a101647541, createdName=Mokgreen , createdTime=Thu Sep 10 21:39:00 CST 2015, time=2015-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36688, encodeId=24ba3668847, content=院长大人威武!, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150901/IMG55E5AEBA878A11723.jpg, createdBy=1a101647541, createdName=Mokgreen , createdTime=Thu Sep 10 21:39:00 CST 2015, time=2015-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36614, encodeId=558736614f1, content=赞\(≧▽≦)/, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=121e1622385, createdName=chenhui888, createdTime=Thu Sep 10 09:23:00 CST 2015, time=2015-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36611, encodeId=d5193661192, content=陈绍良果然厉害,是PCI一把好手!临床与科研齐头并进的人物, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed Sep 09 22:52:00 CST 2015, time=2015-09-09, status=1, ipAttribution=)]
    2015-09-10 chenhui888

    赞\(≧▽≦)/

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=36686, encodeId=8d1836686a9, content=院长大人威武!, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150901/IMG55E5AEBA878A11723.jpg, createdBy=1a101647541, createdName=Mokgreen , createdTime=Thu Sep 10 21:39:00 CST 2015, time=2015-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36687, encodeId=d2993668e28, content=院长大人威武!, beContent=null, objectType=article, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150901/IMG55E5AEBA878A11723.jpg, createdBy=1a101647541, createdName=Mokgreen , createdTime=Thu Sep 10 21:39:00 CST 2015, time=2015-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36688, encodeId=24ba3668847, content=院长大人威武!, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150901/IMG55E5AEBA878A11723.jpg, createdBy=1a101647541, createdName=Mokgreen , createdTime=Thu Sep 10 21:39:00 CST 2015, time=2015-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36614, encodeId=558736614f1, content=赞\(≧▽≦)/, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=121e1622385, createdName=chenhui888, createdTime=Thu Sep 10 09:23:00 CST 2015, time=2015-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36611, encodeId=d5193661192, content=陈绍良果然厉害,是PCI一把好手!临床与科研齐头并进的人物, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed Sep 09 22:52:00 CST 2015, time=2015-09-09, status=1, ipAttribution=)]
    2015-09-09 lovetcm

    陈绍良果然厉害,是PCI一把好手!临床与科研齐头并进的人物

    0

相关资讯

ESC 2015:年轻糖尿病女性心脏病的发病风险可高达6倍

年轻糖尿病女性心脏病的发病风险可高达6倍研究发现年轻糖尿病女性可有高达6倍的心脏病发病风险,研究共纳入了7000名45岁及以下的女性。研究还指出,论心脏病的发病风险,吸烟较老龄大一些。心血管疾病主要影响老年人群,但是近些年来,年轻人(不分性别)的发病率也越来越高。据WHO统计,心血管疾病所致的女性死亡占女性总死亡的52%,而且这个比例正不断加大。心脏病发作患者中1%为年轻女性。与无MI病史的女性相

Ann Intern Med:强直性脊柱炎可增加患者心血管和脑血管疾病的死亡率

Ann Intern Med:强直性脊柱炎或可增加患者心血管和脑血管疾病的死亡率近日有研究表明,强直性脊柱炎可增加心血管或脑血管疾病死亡率的风险,该研究成果于2015年8月11日在线发表于Ann Intern Med。强直性脊柱炎(AS)是一种主要侵犯于年轻人脊柱的慢性炎症性关节炎,既往研究表明强直性脊柱炎可增加心血管及脑血管疾病死亡率。本研究以人群为基础,采用回顾性队列研究分析研究加拿大的健康管

AHA声明:手机App应用可有助于心血管健康的管理

尽管我们目前可以获得诸如智能手机里各种App应用及运动传感程序等数不胜数的健康工具来管理心血管风险因素,但这些工具的效果却并未得到证实。尽管如此,临床医生仍鼓励患者使用这些工具来管理自身的心血管风险。因此,亟需研究以探究这些工具的有效性。8月13日,针对此问题美国心脏学会(AHA)在circulation上发表了科学声明。该声明由Dr Lora Burke及其同事所制定,主要分析了移动端健康工具对

依折麦布药物或降低急性冠脉综合征患者的发病率!

依折麦布可降低糖尿病患者和急性冠脉综合征患者的心血管疾病的发病率,根据布莱根妇女医院的心内科医生Robert Giugliano博士进行的IMPROVE-IT试验指出,依折麦布比单独使用他汀类药物降低低密度脂蛋白胆固醇的效果更好,从而可降低糖尿病患者心脑血管事件发生的风险。“急性冠脉综合征,包括心肌梗塞和不稳定型心绞痛(心梗先兆),是世界各地民众死亡和心功能不全的主要原因,”Robert Giug

Lancet Dia & Endo:服用Albiglutide对心血管安全性的研究

Albiglutide是胰高血糖素样肽-1受体激动剂,是一类新的用于治疗2型糖尿病的药物。研究人员进行了一项前瞻性研究的荟萃分析,由美国食品和药物管理局建议糖尿病新疗法的评价,评估albiglutide心血管安全性。研究人员对8个3期临床试验,一个2b期试验做了荟萃分析,患者被随机分配接受albiglutide,安慰剂或活性对照药物(格列美脲,甘精胰岛素,赖脯胰岛素,利拉鲁肽,吡格列酮,或西格列汀

2014年中国心血管病报告正式发布!

我国心血管病危险因素流行趋势明显,导致了心血管病的发病人数增加。总体上看,我国心血管病患病率及死亡率仍处于上升阶段。心血管病占居民疾病死亡构成的40%以上,为我国居民的首位死因。心血管病负担日渐加重,已成为重大的公共卫生问题,防治心血管病刻不容缓。 随着社会经济的发展,国民生活方式发生了深刻的变化。尤其是人口老龄化及城镇化进程的加速,中国心血管病危险因素流行趋势呈明显上升态势,导致了心血管